HighRes, Novo Nordisk collaborate on robotics platform for drug discovery
HighRes will integrate a multi-system robotics platform with advanced software control architecture for peptide and large molecule therapeutics…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Jan 20
HighRes will integrate a multi-system robotics platform with advanced software control architecture for peptide and large molecule therapeutics…
Chemotherapy is used to treat solid tumours, which account for more than 40% of cancers
A number of health sector experts believe PrEP can reduce the likelihood of getting HIV by 99% when…
The new drug differs from many established acute migraine treatments by lowering blood pressure, rather than raising it
11 Nov 19
The BELIEVE trial has reached both primary and secondary end points and REBLOZYL has demonstrated reduced RBC transfusion…
21 Oct 19
The previous phase 2 study of MOB-015 showed the delivery of high microgram levels of terbinafine into the…
21 Oct 19
FDA approval of ULTOMIRIS based on data from two global, single-arm open-label studies of ULTOMIRIS, separately in adults…
Trinity College scientists claim to have identified a protein linked to lower blood sugar levels that may help…
18 Sep 19
The US Food and Drug Administration (FDA) has approved Mylan’s Abbreviated New Drug Application (ANDA) for the product
06 Sep 19
SunGen has opened its injectable division through the acquisition of a New Jersey-based pharmaceutical company